These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing. Epstein BE; Schaffer DV Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152 [TBL] [Abstract][Full Text] [Related]
3. Off-target effects of engineered nucleases. Yee JK FEBS J; 2016 Sep; 283(17):3239-48. PubMed ID: 27208701 [TBL] [Abstract][Full Text] [Related]
4. Genome editing technologies to fight infectious diseases. Trevisan M; Palù G; Barzon L Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592 [TBL] [Abstract][Full Text] [Related]
5. Genome editing comes of age. Kim JS Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630 [TBL] [Abstract][Full Text] [Related]
6. Genome engineering in human cells. Song M; Kim YH; Kim JS; Kim H Methods Enzymol; 2014; 546():93-118. PubMed ID: 25398337 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic editing of hepatocyte genome in vivo. Ruiz de Galarreta M; Lujambio A J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665 [TBL] [Abstract][Full Text] [Related]
8. Delivery technologies for genome editing. Yin H; Kauffman KJ; Anderson DG Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020 [TBL] [Abstract][Full Text] [Related]
9. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN. Ul Ain Q; Chung JY; Kim YH J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825 [TBL] [Abstract][Full Text] [Related]
10. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing. Liu J; Shui SL J Control Release; 2016 Dec; 244(Pt A):83-97. PubMed ID: 27865852 [TBL] [Abstract][Full Text] [Related]
11. Refining strategies to translate genome editing to the clinic. Cornu TI; Mussolino C; Cathomen T Nat Med; 2017 Apr; 23(4):415-423. PubMed ID: 28388605 [TBL] [Abstract][Full Text] [Related]
13. Research on genodermatoses using novel genome-editing tools. Lehmann J; Seebode C; Emmert S J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433 [TBL] [Abstract][Full Text] [Related]
14. Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases. Kaur B; Perea-Gil I; Karakikes I Curr Cardiol Rep; 2018 Jun; 20(7):58. PubMed ID: 29860642 [TBL] [Abstract][Full Text] [Related]
15. Genome Editing of Structural Variations: Modeling and Gene Correction. Park CY; Sung JJ; Kim DW Trends Biotechnol; 2016 Jul; 34(7):548-561. PubMed ID: 27016031 [TBL] [Abstract][Full Text] [Related]
16. [Genome Editing Tools and their Application in Experimental Ophthalmology]. Yanik M; Wende W; Stieger K Klin Monbl Augenheilkd; 2017 Mar; 234(3):329-334. PubMed ID: 28114701 [TBL] [Abstract][Full Text] [Related]
17. Site-Specific Genome Engineering in Human Pluripotent Stem Cells. Merkert S; Martin U Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935 [TBL] [Abstract][Full Text] [Related]
18. The emerging role of viral vectors as vehicles for DMD gene editing. Maggio I; Chen X; Gonçalves MA Genome Med; 2016 May; 8(1):59. PubMed ID: 27215286 [TBL] [Abstract][Full Text] [Related]
20. Designed nucleases for targeted genome editing. Lee J; Chung JH; Kim HM; Kim DW; Kim H Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]